83 related articles for article (PubMed ID: 22795627)
1. Design and synthesis of polyethylene glycol-modified biphenylsulfonyl-thiophene-carboxamidine inhibitors of the complement component C1s.
Subasinghe NL; Khalil E; Travins JM; Ali F; Ballentine SK; Hufnagel HR; Pan W; Leonard K; Bone RF; Soll RM; Crysler CS; Ninan N; Kirkpatrick J; Kolpak MX; Diloreto KA; Eisennagel SH; Huebert ND; Molloy CJ; Tomczuk BE; Gaul MD
Bioorg Med Chem Lett; 2012 Aug; 22(16):5303-7. PubMed ID: 22795627
[TBL] [Abstract][Full Text] [Related]
2. Biphenylsulfonyl-thiophene-carboxamidine inhibitors of the complement component C1s.
Travins JM; Ali F; Huang H; Ballentine SK; Khalil E; Hufnagel HR; Pan W; Gushue J; Leonard K; Bone RF; Soll RM; DesJarlais RL; Crysler CS; Ninan N; Kirkpatrick J; Cummings MD; Huebert N; Molloy CJ; Gaul M; Tomczuk BE; Subasinghe NL
Bioorg Med Chem Lett; 2008 Mar; 18(5):1603-6. PubMed ID: 18242991
[TBL] [Abstract][Full Text] [Related]
3. A novel series of arylsulfonylthiophene-2-carboxamidine inhibitors of the complement component C1s.
Subasinghe NL; Travins JM; Ali F; Huang H; Ballentine SK; Marugán JJ; Khalil E; Hufnagel HR; Bone RF; DesJarlais RL; Crysler CS; Ninan N; Cummings MD; Molloy CJ; Tomczuk BE
Bioorg Med Chem Lett; 2006 Apr; 16(8):2200-4. PubMed ID: 16460935
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of triazolopiperazine-based beta-amino amides as potent, orally active dipeptidyl peptidase IV (DPP-4) inhibitors.
Kowalchick JE; Leiting B; Pryor KD; Marsilio F; Wu JK; He H; Lyons KA; Eiermann GJ; Petrov A; Scapin G; Patel RA; Thornberry NA; Weber AE; Kim D
Bioorg Med Chem Lett; 2007 Nov; 17(21):5934-9. PubMed ID: 17827003
[TBL] [Abstract][Full Text] [Related]
5. Exploration of cathepsin S inhibitors characterized by a triazole P1-P2 amide replacement.
Moss N; Xiong Z; Burke M; Cogan D; Gao DA; Haverty K; Heim-Riether A; Hickey ER; Nagaraja R; Netherton M; O'Shea K; Ramsden P; Schwartz R; Shih DT; Ward Y; Young E; Zhang Q
Bioorg Med Chem Lett; 2012 Dec; 22(23):7189-93. PubMed ID: 23084902
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and SAR of succinamide peptidomimetic inhibitors of cathepsin S.
Chatterjee AK; Liu H; Tully DC; Guo J; Epple R; Russo R; Williams J; Roberts M; Tuntland T; Chang J; Gordon P; Hollenbeck T; Tumanut C; Li J; Harris JL
Bioorg Med Chem Lett; 2007 May; 17(10):2899-903. PubMed ID: 17382545
[TBL] [Abstract][Full Text] [Related]
7. A novel series of potent and selective small molecule inhibitors of the complement component C1s.
Subasinghe NL; Ali F; Illig CR; Jonathan Rudolph M; Klein S; Khalil E; Soll RM; Bone RF; Spurlino JC; DesJarlais RL; Crysler CS; Cummings MD; Morris PE; Kilpatrick JM; Sudhakara Babu Y
Bioorg Med Chem Lett; 2004 Jun; 14(12):3043-7. PubMed ID: 15149641
[TBL] [Abstract][Full Text] [Related]
8. Substituted pyrrolidine-2,4-dicarboxylic acid amides as potent dipeptidyl peptidase IV inhibitors.
Tsai TY; Coumar MS; Hsu T; Hsieh HP; Chien CH; Chen CT; Chang CN; Lo YK; Wu SH; Huang CY; Huang YW; Wang MH; Wu HY; Lee HJ; Chen X; Chao YS; Jiaang WT
Bioorg Med Chem Lett; 2006 Jun; 16(12):3268-72. PubMed ID: 16581245
[TBL] [Abstract][Full Text] [Related]
9. P4 capped amides and lactams as HCV NS3 protease inhibitors with improved potency and DMPK profile.
Nair LG; Sannigrahi M; Bogen S; Pinto P; Chen KX; Prongay A; Tong X; Cheng KC; Girijavallabhan V; George Njoroge F
Bioorg Med Chem Lett; 2010 Jan; 20(2):567-70. PubMed ID: 20004570
[TBL] [Abstract][Full Text] [Related]
10. Identification of a catalytic exosite for complement component C4 on the serine protease domain of C1s.
Duncan RC; Mohlin F; Taleski D; Coetzer TH; Huntington JA; Payne RJ; Blom AM; Pike RN; Wijeyewickrema LC
J Immunol; 2012 Sep; 189(5):2365-73. PubMed ID: 22855709
[TBL] [Abstract][Full Text] [Related]
11. Thiophene and bioisostere derivatives as new MMP12 inhibitors.
Badland M; Compère D; Courté K; Dublanchet AC; Blais S; Manage A; Peron G; Wrigglesworth R
Bioorg Med Chem Lett; 2011 Jan; 21(1):528-30. PubMed ID: 21111619
[TBL] [Abstract][Full Text] [Related]
12. Toward second generation hepatitis C virus NS3 serine protease inhibitors: discovery of novel P4 modified analogues with improved potency and pharmacokinetic profile.
Arasappan A; Padilla AI; Jao E; Bennett F; Bogen SL; Chen KX; Pike RE; Sannigrahi M; Soares J; Venkatraman S; Vibulbhan B; Saksena AK; Girijavallabhan V; Tong X; Cheng KC; Njoroge FG
J Med Chem; 2009 May; 52(9):2806-17. PubMed ID: 19371095
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the proteolytic activity of the complement protease C1s by polyanions: implications for polyanion-mediated acceleration of interaction between C1s and SERPING1.
Murray-Rust TA; Kerr FK; Thomas AR; Wu T; Yongqing T; Ong PC; Quinsey NS; Whisstock JC; Wagenaar-Bos IC; Freeman C; Pike RN
Biochem J; 2009 Aug; 422(2):295-303. PubMed ID: 19522701
[TBL] [Abstract][Full Text] [Related]
14. Early complement proteases: C1r, C1s and MASPs. A structural insight into activation and functions.
Gál P; Dobó J; Závodszky P; Sim RB
Mol Immunol; 2009 Sep; 46(14):2745-52. PubMed ID: 19477526
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 1.
Liu H; Tully DC; Epple R; Bursulaya B; Li J; Harris JL; Williams JA; Russo R; Tumanut C; Roberts MJ; Alper PB; He Y; Karanewsky DS
Bioorg Med Chem Lett; 2005 Nov; 15(22):4979-84. PubMed ID: 16183279
[TBL] [Abstract][Full Text] [Related]
16. Importance of the prime subsites of the C1s protease of the classical complement pathway for recognition of substrates.
O'Brien G; Quinsey NS; Whisstock JC; Pike RN
Biochemistry; 2003 Dec; 42(50):14939-45. PubMed ID: 14674770
[TBL] [Abstract][Full Text] [Related]
17. Design and Selection of Novel C1s Inhibitors by In Silico and In Vitro Approaches.
Szilágyi K; Hajdú I; Flachner B; Lőrincz Z; Balczer J; Gál P; Závodszky P; Pirli C; Balogh B; Mándity IM; Cseh S; Dormán G
Molecules; 2019 Oct; 24(20):. PubMed ID: 31600984
[TBL] [Abstract][Full Text] [Related]
18. Rational design and synthesis of potent dibenzazepine motifs as beta-secretase inhibitors.
Al-Tel TH; Al-Qawasmeh RA; Schmidt MF; Al-Aboudi A; Rao SN; Sabri SS; Voelter W
J Med Chem; 2009 Oct; 52(20):6484-8. PubMed ID: 19788239
[TBL] [Abstract][Full Text] [Related]
19. Substituted thiophene-anthranilamides as potent inhibitors of human factor Xa.
Kochanny MJ; Adler M; Ewing J; Griedel BD; Ho E; Karanjawala R; Lee W; Lentz D; Liang AM; Morrissey MM; Phillips GB; Post J; Sacchi KL; Sakata ST; Subramanyam B; Vergona R; Walters J; White KA; Whitlow M; Ye B; Zhao Z; Shaw KJ
Bioorg Med Chem; 2007 Mar; 15(5):2127-46. PubMed ID: 17227710
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of brain penetrant selective JNK inhibitors with improved pharmacokinetic properties for the prevention of neurodegeneration.
Bowers S; Truong AP; Jeffrey Neitz R; Hom RK; Sealy JM; Probst GD; Quincy D; Peterson B; Chan W; Galemmo RA; Konradi AW; Sham HL; Tóth G; Pan H; Lin M; Yao N; Artis DR; Zhang H; Chen L; Dryer M; Samant B; Zmolek W; Wong K; Lorentzen C; Goldbach E; Tonn G; Quinn KP; Sauer JM; Wright S; Powell K; Ruslim L; Ren Z; Bard F; Yednock TA; Griswold-Prenner I
Bioorg Med Chem Lett; 2011 Sep; 21(18):5521-7. PubMed ID: 21813278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
